Prognostic Model for Metastatic Renal Cell Carcinoma
Author Information
Author(s): Royston P, Reitz M, Atzpodien J
Primary Institution: MRC Clinical Trials Unit, Cancer Division, Medical Research Council (MRC)
Hypothesis
Can fractional polynomials improve the estimation of prognosis in metastatic renal cell carcinoma?
Conclusion
The fractional polynomial model provides a more flexible and accurate classification of survival times in metastatic renal cell carcinoma patients.
Supporting Evidence
- The MFP algorithm identified five significant prognostic factors.
- Median overall survival varied significantly across risk groups.
- The model allows for continuous predictors to be used without categorization.
Takeaway
This study created a new way to predict how long patients with kidney cancer might live by using a special math method that looks at many factors at once.
Methodology
Retrospective analysis of 425 patients using multivariable fractional polynomial modeling.
Potential Biases
Potential bias due to the retrospective nature of the study and the specific patient population selected.
Limitations
The results may not be generalizable to all metastatic renal cell carcinoma patients as the study focused on those with good performance status.
Participant Demographics
Patients aged 18 to 80 years with histologically confirmed metastatic renal cell carcinoma.
Statistical Information
P-Value
0.005 for lymph node metastases, 0.05 for liver metastases, <0.001 for bone metastases, 0.02 for age, 0.01 for CRP, 0.001 for neutrophils
Confidence Interval
95% CI: 24, 53 for low risk; 95% CI: 20, 27 for low intermediate risk; 95% CI: 13, 20 for high intermediate risk; 95% CI: 4.5, 7.9 for high risk
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website